Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity
- 8 March 2022
- journal article
- research article
- Published by Elsevier BV in Clinics in Laboratory Medicine
- Vol. 42 (2), 261-282
- https://doi.org/10.1016/j.cll.2022.02.006
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health and Human Services
- NIH Clinical Center
This publication has 88 references indexed in Scilit:
- Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal SpecimensJournal of Clinical Microbiology, 2020
- Simulation of pooled-sample analysis strategies for COVID-19 mass testingBulletin of the World Health Organization, 2020
- SARS-CoV-2–Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19Annals of Internal Medicine, 2020
- CRISPR–Cas12-based detection of SARS-CoV-2Nature Biotechnology, 2020
- Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 DetectionACS Nano, 2020
- An alternative workflow for molecular detection of SARS-CoV-2 – escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020Eurosurveillance, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Data, disease and diplomacy: GISAID's innovative contribution to global healthGlobal Challenges, 2017
- The Detection of Defective Members of Large PopulationsThe Annals of Mathematical Statistics, 1943